: Capitalized on the e-commerce boom and rising digital transaction volumes.
Shared value reached approximately market cap, a gain of 87% for the year.
Significant R&D payoffs led to massive gains for select pharmaceutical and health-tech companies.
: Benefited from explosive demand for graphics chips in data centers and artificial intelligence. The stock ended the year with an 81% gain .
Technology was the standout sector in 2017, driven by cloud expansion and digital payment adoption.
: The Invisalign maker dominated the orthodontic market, reaching record annual sales. It was one of the year's top performers with a 131% return .
It ranked among the top 10 S&P 500 performers with an . Biotech and Healthcare Breakthroughs
For long-term stability, analysts highlighted established leaders pivoting into new growth markets. Vertex Pharmaceuticals
: Capitalized on the e-commerce boom and rising digital transaction volumes.
Shared value reached approximately market cap, a gain of 87% for the year.
Significant R&D payoffs led to massive gains for select pharmaceutical and health-tech companies. best stocks to buy right now 2017
: Benefited from explosive demand for graphics chips in data centers and artificial intelligence. The stock ended the year with an 81% gain .
Technology was the standout sector in 2017, driven by cloud expansion and digital payment adoption. : Capitalized on the e-commerce boom and rising
: The Invisalign maker dominated the orthodontic market, reaching record annual sales. It was one of the year's top performers with a 131% return .
It ranked among the top 10 S&P 500 performers with an . Biotech and Healthcare Breakthroughs : Benefited from explosive demand for graphics chips
For long-term stability, analysts highlighted established leaders pivoting into new growth markets. Vertex Pharmaceuticals